HMVSX
Price
$19.71
Change
-$0.16 (-0.81%)
Updated
Sep 20 closing price
JVMTX
Price
$30.35
Change
-$0.19 (-0.62%)
Updated
Sep 20 closing price
Ad is loading...

HMVSX vs JVMTX

Header iconHMVSX vs JVMTX Comparison
Open Charts HMVSX vs JVMTXBanner chart's image
Hartford MidCap Value R4
Price$19.71
Change-$0.16 (-0.81%)
VolumeN/A
CapitalizationN/A
JHancock Disciplined Value Mid Cap R4
Price$30.35
Change-$0.19 (-0.62%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HMVSX vs JVMTX Comparison Chart
Loading...
VS
HMVSX vs. JVMTX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMVSX is a Buy and JVMTX is a Buy.

FUNDAMENTALS
Fundamentals
JVMTX has more cash in the bank: 23.4B vs. HMVSX (1.08B). JVMTX pays higher dividends than HMVSX: JVMTX (0.73) vs HMVSX (0.35). HMVSX was incepted earlier than JVMTX: HMVSX (14 years) vs JVMTX (11 years). HMVSX is a more actively managed with annual turnover of: 84.00 vs. JVMTX (41.00). HMVSX (0) and JVMTX (0) have matching initial minimum investment requirements. JVMTX annual gain was more profitable for investors over the last year : 19.27 vs. HMVSX (17.29). JVMTX return over 5 years is better than : 43.64 vs. HMVSX (29.48).
HMVSXJVMTXHMVSX / JVMTX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years11 years-
Gain YTD11.98911.010109%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.08B23.4B5%
Annual Yield % from dividends0.350.7348%
Returns for 1 year17.2919.2790%
Returns for 3 years7.2613.3854%
Returns for 5 years29.4843.6468%
Returns for 10 years15.1063.3424%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVR0.78-0.01
-0.85%
AlloVir
LEA108.02-2.00
-1.82%
Lear Corp
RWAY10.13-0.24
-2.31%
Runway Growth Finance Corp
SLNO51.50-1.23
-2.33%
Soleno Therapeutics
TIVC0.27-0.01
-3.57%
Tivic Health Systems